Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) Interest Expenses (2018 - 2026)

Achieve Life Sciences (ACHV) has disclosed Interest Expenses for 7 consecutive years, with $274000.0 as the latest value for Q1 2026.

  • Quarterly Interest Expenses rose 48.11% to $274000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $908000.0 through Mar 2026, down 41.49% year-over-year, with the annual reading at $819000.0 for FY2025, 62.43% down from the prior year.
  • Interest Expenses for Q1 2026 was $274000.0 at Achieve Life Sciences, up from $251000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $813000.0 in Q1 2024, with the low at $185000.0 in Q1 2025.
  • Average Interest Expenses over 5 years is $465588.2, with a median of $404000.0 recorded in 2022.
  • The sharpest move saw Interest Expenses skyrocketed 76.24% in 2023, then plummeted 77.24% in 2025.
  • Achieve Life Sciences' Interest Expenses stood at $547000.0 in 2022, then soared by 43.88% to $787000.0 in 2023, then tumbled by 74.97% to $197000.0 in 2024, then rose by 27.41% to $251000.0 in 2025, then grew by 9.16% to $274000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Interest Expenses are $274000.0 (Q1 2026), $251000.0 (Q4 2025), and $192000.0 (Q3 2025).